Transforming growth factor β1 enhances adhesion of endometrial cells to mesothelium by regulating integrin expression

Hee-Jung Choi, Mi-Ju Park, Park MJ, Kim BS, Bo-Sung Kim, Bosung Kim, Hee-Jin Choi, Choi HJ, Bosun Joo, Joo B, Bo‐Sun Joo, Kyu Sup Lee, Lee KS, Jung-Hye Choi, Choi JH, Jung‐Hye Choi, Tae-Wook Chung, Tae‐Wook Chung, Ki‐Tae Ha, Ki-Tae Ha, Ha KT
BMB reports · 2017 · vol. 50(8) , pp. 429–434 · doi:10.5483/bmbrep.2017.50.8.097 · PMID:28760197 · PMC5595173 · W2753096590
article OA: gold CC0 ⤵ 19 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Transforming growth factor β1 enhances endometrial cell adhesion to mesothelium by upregulating integrins αV, β1, and β4 through the TGF-β1/TGF-βRI/Smad2 signaling pathway.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text ⓘ

The study investigated how transforming growth factor-β1 (TGF-β1) influences adhesion between endometrial epithelial cells and mesothelial cells, comparing normal human endometrial cells (HES) with endometriosis-derived epithelial cells (12Z) and using mesothelial (Met-5A) cells. TGF-β1 was expressed at higher levels in 12Z cells, and both TGF-β1 stimulation and TGF-β receptor I inhibition (SB-525334) altered endometrial–mesothelial adhesion via TGF-βRI/Smad2 signaling; the authors also found that TGF-β1 induced expression of integrins αV, α6, β1, and β4. Neutralizing antibodies against integrin subunits reduced the TGF-β1-enhanced adhesion, supporting that TGF-β1 promotes adhesion through integrin heterodimers αVβ1, α6β1, and α6β4, with the caveat that work was performed in cell models rather than in vivo. This paper is centrally about endometriosis — it provides mechanistic evidence that TGF-β1 enhances endometrial epithelial adhesion to mesothelium via integrin regulation, a key early step in endometriosis initiation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is the abnormal growth of endometrial cells outside the uterus, causing pelvic pain and infertility. Furthermore, adhesion of endometrial tissue fragments to pelvic mesothelium is required for the initial step of endometriosis formation outside uterus. TGF-β1 and adhesion molecules importantly function for adhesion of endometrial tissue fragments to mesothelium outside uterus. However, the function of TGF-β1 on the regulation of adhesion molecule expression for adhesion of endometrial tissue fragments to mesothelium has not been fully elucidated. Interestingly, transforming growth factor β1 (TGF-β1) expression was higher in endometriotic epithelial cells than in normal endometrial cells. The adhesion efficiency of endometriotic epithelial cells to mesothelial cells was also higher than that of normal endometrial cells. Moreover, TGF-β1 directly induced the adhesion of endometrial cells to mesothelial cells through the regulation of integrin of αV, α6, β1, and β4 via the activation of the TGF-β1/TGF-βRI/Smad2 signaling pathway. Conversely, the adhesion of TGF-β1-stimulated endometrial cells to mesothelial cells was clearly reduced following treatment with neutralizing antibodies against specific TGF-β1-mediated integrins αV, β1, and β4 on the endometrial cell membrane. Taken together, these results suggest that TGF-β1 may act to promote the initiation of endometriosis by enhancing integrin-mediated cell-cell adhesion. [BMB Reports 2017; 50(8): 429-434].
Full text 12,666 characters · extracted from pmc-nxml · 4 sections · click to expand

Intro

Endometriosis is a common gynecological disorder defined as growth of endometrial tissues outside the uterus. Possible causes include retrograde menstruation, immunological disorders, invasive implantation, and ectopic growth of endometrial tissues ( 1 , 2 ). However, the precise mechanisms that underlie the initial development and subsequent progression of endometriosis are not clear. At the initial stages of the disease, the attachment of retrograde endometrial tissues onto the pelvic mesothelium is a critical step. Several adhesion molecules, including integrin αvβ3, α4β1, VCAM-1, and Nectin-4, have been suggested to be key factors in regulating the attachment of endometrial and mesothelial tissues ( 3 – 6 ). Furthermore, while previous studies have demonstrated that these adhesion molecules are regulated by cytokines and growth factors ( 7 – 12 ), the mechanisms that underlie this regulation are still not clear. Transforming growth factor-β (TGF-β) is a 25 kDa peptide that plays key roles in the progression of endometriosis ( 13 ). TGF-β expression is higher in the serum, peritoneal fluid, and cyst tissues of patients with endometriosis than in women without endometriosis ( 14 – 16 ). Among the three subtypes of TGF-βs, TGF-β1 is generally considered to be a key player in the pathogenesis of endometriosis, due to its pattern of expression and correlation with disease progression ( 13 , 17 ). TGF-β1 is involved in the suppression of immune surveillance, cell adhesion and invasion into the peritoneum, and in the growth of implants ( 13 ). Peritoneal adhesion of endometrial cells, in particular, is elevated in the presence of TGF-β1 ( 18 , 19 ). The expression of several integrins in different cells is controlled by TGF-β1 ( 20 – 23 ); therefore it was suggested that cell-cell interactions that are activated by TGF-β1 could be mediated by integrins ( 13 ). To date, there have been no reports describing direct evidence for TGF-β1-mediated regulation of integrins and other adhesion molecules in endometrial cells, or its role in peritoneal adhesion of retrograde endometrium. In the present study, we demonstrated that autocrine secretion of TGF-β1 increased adhesion between endometrial and mesothelial cells through expression of integrin αV, α6, β1, and β4. Moreover, blocking these integrins with neutralizing antibodies suppressed the mesothelial adhesion of endometrial cells. Thus, we suggest that TGF-β1 may act to promote the initiation of endometriosis by enhancing integrin-mediated cell-cell adhesion.

Results

It has been reported that TGF-β1 expression is increased in the peritoneal fluid of women with endometriosis ( 13 , 24 ). In the current study, we compared levels of TGF-β1 expression in normal human endometrial cells (HES cells) and human endometriotic epithelial cells from endometrial lesions (12Z cells). As shown in Fig. 1A , TGF-β1 expression was significantly higher in 12Z cells than in HES cells. Results from several recent studies have suggested that proliferative, secretory, and menstrual endometrial fragments rapidly attach to the peritoneal mesothelium in case of endometriosis ( 25 – 28 ). Therefore, we also investigated differences in the adhesion of HES and 12Z cells to human mesothelial cells (Met-5A). As shown in Fig. 1B , the adhesion ratio of 12Z cells to Met-5A cells was approximately 3 times higher than that of HES cells. Because TGF-β1 expression and adhesion were higher in endometriotic epithelial cells than in normal endometrial cells, we examined whether TGF-β1-mediated signaling is involved in the adhesion of 12Z cells to Met-5A cells. Interestingly, adhesion rate of TGF-β receptor I (TGF-βRI) inhibitor (SB-525334, Sigma, St. Louis, MO, USA)-treated 12Z cells to Met-5A cells was lower than that of 12Z cells ( Fig. 1C ). These results suggest that enhanced expression of TGF-β1 in 12Z cells affects the adhesion of endometrial cells to mesothelial cells, thus playing a role in the progression of endometriosis. Secretion of TGF-β into the peritoneal fluid plays an important role in the establishment of endometriosis ( 13 , 24 ). Thus, we investigated whether TGF-β1 played a role in the initial stages of endometriosis formation outside the uterus via direct induction of the adhesion of endometrial cells to mesothelial cells. Adhesion rates of TGF-β1-stimulated HES and 12Z cells to Met-5A cells were clearly higher than that of untreated HES and 12Z cells ( Fig. 2A ). Furthermore, TGF-β1 significantly induced the adhesion of normal endometrial cells to mesothelial cells through activation of Smad-2 signaling. However, treatment with a TGF-βRI inhibitor markedly suppressed the TGF-β1-induced adhesion of HES cells to Met-5A cells by inhibition of the TGF-βRI/Smad2 signaling pathway ( Fig. 2B and C ). Adhesion molecules, including integrins, CD44, ICAM-1, L-selectin and E-cadherin ( 29 ) and TGF-β1, play pivotal roles in the attachment of endometrial cells outside the uterus i.e., the initiation of endometriosis; however, to the best of our knowledge, there is no direct evidence for a regulatory function of TGF-β1 on expressions of adhesion molecules. As shown in Fig. 3A , TGF-β1 induced the expression of integrins αV, α6, β1, and β4. The expression levels of integrin β5, CD44s, ICAM-1, and L-selectin were not increased by TGF-β1 treatment, and integrin β3 and E-cadherin were not detectable under the same conditions. To further investigate this result, we used a TGF-βRI inhibitor and measured levels of integrin αV, α6, β1, and β4 mRNA expression. Treatment with the TGF-βRI inhibitor clearly reduced integrin expression levels (αV, α6, β1, and β4) in HES cells induced by TGF-β1 ( Fig. 3B ). Thus, our data showed that TGF-β1 induced adhesion of endometrial cells to mesothelial cells by enhancing the expression of integrins αV, α6, β1, and β4. We then started to investigate whether integrin subunits αV, β1, and β4 regulated the adhesion of endometrial cells to mesothelial cells through TGF-β1-induced expression of integrin heterodimers αVβ1, α6β1, and α6β4 in endometrial cells. We assessed the adhesion of TGF-β1-stimulated endometrial cells to mesothelial cells in the presence of neutralizing antibodies against integrin subunits αV, β1, and β4. As shown in Fig. 4 , TGF-β1 greatly enhanced the adhesion of endometrial cells to mesothelial cells. However, this adhesion was significantly reduced when the TGF-β1-mediated expression levels of integrin dimers αVβ1, α6β1, and α6β4 on endometrial cell surfaces were disrupted by neutralizing antibodies ( Fig. 4 ). These results suggested that secreted TGF-β1 may play a role in the adhesion of endometrial fragments generated by menstruation and the passage of these fragments outside the uterus, where endometriosis is initiated through attachment to the mesothelium. The molecular mechanism involves enhanced expression of integrin heterodimers αVβ1, α6β1, and α6β4 in endometrial cells.

Discussion

Integrins are heterodimeric membrane proteins composed of non-covalently associated α and β subunits, that are essential for linking the extracellular matrix to the cytoskeleton. In mammals, there are 18 α subunits and 8 β subunits that can assemble into 24 different αβ combinations ( 30 ). The role of integrins in the reproductive system has been studied for over 20 years. A major focus of these studies has been the involvement of these transmembrane receptors in embryo-endometrial interactions during the implantation window ( 31 ). Many researchers have continued to work towards elucidating the function of integrins during endometriosis ( 32 ) and have identified potential biomarkers for use in diagnosis and treatment of the disease ( 33 ). Several integrins, including αvβ3, αvβ5, αvβ6, α4β1, and α6β1, have been reported to mediate the attachment of endometrial cells to the mesothelium ( 4 , 34 – 36 ). The expression of these integrins is tightly regulated by diverse molecules, such as interleukin (IL)-1, IL-8, macrophage inhibitory factor (MiR)-183, prostaglandin E2, and a cannabinoid receptor agonist ( 7 , 9 – 11 , 37 , 38 ). However, despite the obvious importance of TGF-β1 in the progression of endometriosis ( 13 , 17 ), there have been no reports of the TGF-β1 function in the regulation of integrins in endometrial cells. Thus, we examined the regulation of integrins by TGF-β1 and their role in the initiation of endometriosis. First, we confirmed the correlation between endometrial-mesothelial adhesion and TGF-β expression. Our results clearly showed that autocrine expression of TGF-β1 in endometrial cells positively regulated their attachment to mesothelial cells. In human endometriosis lesions, TGF-β1 expression has been found in macrophages, endometrial epithelial cells, endometrial stromal cells, and mesothelial cells ( 13 , 24 ). Elevated levels of secreted TGF-β1 in peritoneal fluid influenced many steps in the progression of endometriosis, including immune surveillance, cell adhesion and invasion into the peritoneum, angiogenesis, and growth of implants ( 13 , 17 ). The response of TGF-β1 measured by endometrial-mesothelial adhesion is different between normal endometrial HES cells and ectopic endometrial cells (12Z). Rai et al . ( 39 ) reported that expression of adhesion molecules is different between the normal endometrium and endometriosis tissues. Thus, we proposed that it might be caused by elevated expression of TGF-β1 in 12Z cells. We further showed that the use of a specific TGF-β RI inhibitor to inhibit the activity of TGF-β1 activity greatly reduced mesothelial adhesion of TGF-β1-stimulated HES cells. From these results, we postulated that secreted TGF-β1 may act in an autocrine fashion on endometrial-mesothelial interactions. To identify the factors that mediate TGF-β1-enhanced cell-cell interactions, we analyzed the expression of several adhesion molecules that are known to be important in the development of endometriosis ( 40 , 41 ). Levels of integrins αv, α6, β1 and β4 mRNA were clearly increased following TGF-β1 treatment. The expression levels of integrin β5, CD44s, ICAM-1, L-selectin were not increased, and integrin β3 and E-cadherin were not detectable under the same conditions. We further suppressed the activity of activity of TGF-β1 by examining whether the expression levels of integrins αV, α6, β1, and β4 were dependent on TGF-β1. Previous studies reported that several integrins, such as αV, β1, and β3, were positively regulated by TGF-β1 in fibroblast, glioblastoma, and kidney epithelial cells ( 23 , 42 , 43 ). In the present study, expression levels of integrins αV, α6, and β1 were increased in normal endometrial HES cells following TGF-β1 treatment, but integrin β3 expression was not affected by the same conditions. In A549 lung cancer cells, sustained ERK activity induced by TGF-β1 is involved in the induction of integrin β3 ( 44 ). In the current study, phosphorylation of Smad2 was found to be a major step in the signaling pathway involved in TGF-β1-stimulated integrin expression and endometrial-mesothelial adhesion. Previous studies demonstrated that integrin β4 is negatively regulated by TGF-β1 in fibroblast and mammary gland cells via epigenetic modifications ( 45 , 46 ). By contrast, we found that TGF-β1 increased the expression of integrin β4 in endometrial cells. Although the precise molecular machinery involved in the modulation of integrin β4 by TGF-β1 is not fully elucidated, we hypothesize that the differential expression of integrin β4 is mainly due to tissue specificity. Next, we confirmed the role of induced integrins on endometrial-mesothelial attachment by neutralizing the action of integrins in endometrial cells. Addition of antibodies against integrins αV, β1, and β4 significantly blocked the adhesion of endometrial cells onto mesothelium. To the best our knowledge, this is the first report to show that blocking the functions of integrins αV, β1, and β4 with neutralizing antibodies reduced the development of endometriosis by inhibiting endometrial-mesothelial adhesion. In conclusion, as illustrated in supplementary Fig. 1 , we demonstrated that TGF-β1 increased endometrial-mesothelial adhesion via autocrine regulation. This TGF-β1-stimulated adhesion is mediated by integrins αV, α6, β1, and β4, and blocking these integrins with neutralizing antibodies reduced the mesothelial adhesion of endometrial cells. We therefore propose that TGF-β1-stimulation of integrins αV, α6, β1, and β4 could be a good target for the development of new methods aimed at preventing or treating endometriosis.

Materials|Methods

See supplementary information .

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Endometriosis Integrins Transforming Growth Factor beta1 Cell Adhesion Cell Adhesion Cell Adhesion Molecules Cell Adhesion Molecules Cells, Cultured Endometriosis Epithelial Cells Epithelial Cells Epithelial Cells Epithelium Epithelium Epithelium Female Humans Integrins Integrins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (46)

Cited by (22)

Source provenance

europepmc
last seen: 2026-09-21T06:08:07.822426+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:19.560968+00:00
License: CC0 · commercial use OK